Beneficial effects of myocardial postconditioning are associated with reduced oxidative stress in a senescent mouse model

Transplantation

Volumn 85, Issue 12, 2008, Pages 1802-1808

  Lauzier, Benjamin ^a,d   Delemasure, Stéphanie ^a   Debin, Régine ^a   Collin, Bertrand ^a   Sicard, Pierre ^a   Acar, Niyazi ^b   Bretillon, Lionel ^b   Joffre, Corinne ^b   Bron, Alain ^b,c   Creuzot Garcher, Catherine ^b,c   Vergely, Catherine ^a   Rochette, Luc ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d NONE   (France)

Author keywords

Isolated working mouse heart; Oxidative stress; Postconditioning; Senescence

Indexed keywords

COLLAGEN; LIPID; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; HEART ISCHEMIC POSTCONDITIONING; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PROTECTION; HEART RATE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; SENESCENCE ACCELERATED MOUSE; AGING; ANIMAL; AORTA; DISEASE MODEL; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; METABOLISM; MOUSE STRAIN; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ANIMALS; AORTA; CARDIAC OUTPUT; COLLAGEN; DISEASE MODELS, ANIMAL; HEART RATE; HEART TRANSPLANTATION; MICE; MICE, INBRED STRAINS; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; REPERFUSION INJURY; SUPEROXIDES; VENTRICULAR FUNCTION, LEFT;

EID: 49149114787     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181775367     Document Type: Article

References (42)

1. Powers SK, Quindry J, Hamilton K. Aging, exercise, and cardioprotection. Ann N Y Acad Sci 2004; 1019: 462.
2. Kass DA. Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 2005; 46: 185.
3. Lakatta EG. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Part III: Cellular and molecular clues to heart and arterial aging. Circulation 2003; 107: 490.
4. Besse S, Bulteau AL, Boucher F, et al. Antioxidant treatment prevents cardiac protein oxidation after ischemia-reperfusion and improves myocardial function and coronary perfusion in senescent hearts. J Physiol Pharmacol 2006; 57: 541.
5. Takeda T, Hosokawa M, Takeshita S, et al. A new murine model of accelerated senescence. Mech Ageing Dev 1981; 17: 183.
6. Butterfield DA, Poon HF. The senescence-accelerated prone mouse (SAMP8): A model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp Gerontol 2005; 40: 774.
7. Takeda T, Matsushita T, Kurozumi M, et al. Pathobiology of the senescence-accelerated mouse (SAM). Exp Gerontol 1997; 32: 117.
8. Nakahara H, Kanno T, Inai Y, et al. Mitochondrial dysfunction in the senescence accelerated mouse (SAM). Free Radic Biol Med 1998; 24: 85.
9. Sureda FX, Gutierrez-Cuesta J, Romeu M, et al. Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-accelerated mice SAMP-8. Exp Gerontol 2006; 41: 360.
10. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579.
11. Galagudza M, Kurapeev D, Minasian S, et al. Ischemic postconditioning: Brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm.EurJ Cardiothorac Surg 2004; 25: 1006.
12. Sun HY, Wang NP, Halkos M, et al. Postconditioning attenuates cardiomyocyte apoptosis via inhibitionof JNK and p38 mitogen-activated protein kinase signaling pathways. Apoptosis 2006; 11: 1583.
13. Ebrahim Z, Yellon DM, Baxter GF. Ischemic preconditioning is lost in aging hypertensive rat heart: Independent effects of aging and longstanding hypertension. Exp Gerontol 2007; 42: 807.
14. Bartling B, Friedrich I, Silber RE, et al. Ischemic preconditioning is not cardioprotective in senescent human myocardium. Ann Thorac Surg 2003; 76: 105.
15. Bartling B, Hilgefort C, Friedrich I, et al. Cardio-protective determinants are conserved in aged human myocardium after ischemic preconditioning. FEBS Lett 2003; 555: 539.
16. Iliodromitis EK, Zoga A, Vrettou A, et al. The effectiveness of postcon-ditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 2006; 188: 356.
17. Koerner MM. Good news for donor hearts: Postconditioning. Transplantation 2007; 84: 1382.
18. Lauzier B, Sicard P, Bouchot O, et al. After four hours of cold ischemia and cardioplegic protocol, the heart can still be rescued with postcon-ditioning. Transplantation 2007; 84: 1474.
19. Sicard P, Acar N, Gregoire S, et al. Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats. Br J Pharmacol 2007; 151: 979.
20. Collin B, Busseuil D, Korandji C, et al. Short-term atorvastatin treatment does not modify neointimal morphology but reduces MMP-2 expression in normocholesterolemic rabbit stented arteries. J Cardiovasc Pharmacol 2006; 47: 428.
21. Rodriguez MI, Carretero M,Escames G,et al. Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence- accelerated mice. Free Radic Res 2007; 41: 15.
22. Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Part I: Aging arteries: A "set up" for vascular disease. Circulation 2003; 107: 139.
23. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 2006; 82: 357.
24. Ungvari Z, Csiszar A, Kaley G. Vascular inflammation in aging. Herz 2004; 29: 733.
25. Yoon SO, Yun CH, Chung AS. Dose effect of oxidative stress on signal transduction in aging. Mech Ageing Dev 2002; 123: 1597.
26. Oudot A, Martin C, Busseuil D, et al. NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging. Free Radic Biol Med 2006; 40: 2214.
27. Ferrara N, O'Gara P, Wynne DG, et al. Decreased contractile responses to isoproterenol in isolated cardiac myocytes from aging guineapigs. J Mol Cell Cardiol 1995; 27: 1141.
28. Rosenfeldt FL, Pepe S, Linnane A, et al. The effects of ageing on the response to cardiac surgery: Protective strategies for the ageing myocardium. Biogerontology 2002; 3: 37.
29. Nitahara JA, Cheng W, Liu Y, et al. Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. J Mol Cell Cardiol 1998; 30: 519.
30. Marcil M, Ascah A, Matas J, et al. Compensated volume overload increases the vulnerability of heart mitochondria without affecting their functions in the absence of stress. J Mol Cell Cardiol 2006; 41: 998.
31. Takeda T, Higuchi K, Hosokawa M. Senescence-accelerated mouse (SAM): With special reference to development and pathological Phenotypes. ILAR J 1997; 38: 109.
32. Rebrin I, Sohal RS. Comparison of thiol redox state of mitochondria and homogenates of various tissues between two strains of mice with different longevities. Exp Gerontol 2004; 39: 1513.
33. Fenton RA, Dickson EW, Meyer TE, et al. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J Mol Cell Cardiol 2000; 32: 1371.
34. TaniM,SuganumaY, Hasegawa H, et al. Changesin ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation 1997; 95: 2559.
35. Burns PG, Krunkenkamp IB, Calderone CA, et al. Is the preconditioning response conserved in senescent myocardium? Ann Thorac Surg 1996; 61: 925.
36. Abete P, Ferrara N, Cioppa A, et al. Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol 1996; 27: 1777.
37. Park AM, NagaseH, Kumar SV, et al. Effectsof intermittent hypoxia on the heart. Antioxid Redox Signal 2007; 9: 723.
38. Gateau-Roesch O, Argaud L, Ovize M. Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 2006; 70: 264.
39. Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning: Staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 2007; 115: 1895.
40. Vergely C, Maupoil V, Clermont G, et al. Identification and quantification of free radicals during myocardial ischemia and reperfusion using electron paramagnetic resonance spectroscopy. Arch Biochem Biophys 2003; 420: 209.
41. Vergely C, Maupoil V, Benderitter M, et al. Influence of the severity of myocardial ischemia onthe intensityof ascorbyl free radical release and on postischemic recovery during reperfusion. Free Radic Biol Med 1998; 24: 470.
42. Durot I, Maupoil V, Ponsard B, et al. Oxidative injury of isolated cardiomyocytes: Dependence on free radical species. Free Radic Biol Med 2000; 29: 846.